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RESEARCH ARTICLE
Effect of tissue permeability and drug diffusion anisotropy on
convection-enhanced delivery
Wenbo Zhan, Ferdinando Rodriguez y Baena and Daniele Dini
Department of Mechanical Engineering, Imperial College London, London, UK
ABSTRACT
Although convection-enhanced delivery (CED) can successfully facilitate a bypass of the blood brain
barrier, its treatment efficacy remains highly limited in clinic. This can be partially attributed to the
brain anisotropic characteristics that lead to the difficulties in controlling the drug spatial distribution.
Here, the responses of six different drugs to the tissue anisotropy are examined through a parametric
study performed using a multiphysics model, which considers interstitial fluid flow, tissue deformation
and interlinked drug transport processes in CED. The delivery outcomes are evaluated in terms of the
penetration depth and delivery volume for effective therapy. Simulation results demonstrate that the
effective penetration depth in a given direction can be improved with the increase of the correspond-
ing component of anisotropic characteristics. The anisotropic tissue permeability could only reshape
the drug distribution in space but has limited contribution to the total effective delivery volume. On
the other hand, drugs respond in different ways to the anisotropic diffusivity. The large delivery vol-
umes of fluorouracil, carmustine, cisplatin and doxorubicin could be achieved in relatively isotropic tis-
sue, while paclitaxel and methotrexate are able to cover enlarged regions into anisotropic tissues.
Results obtained from this study serve as a guide for the design of CED treatments.
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Routine drug delivery into brain through intravenous admin-
istration is less effective in clinic, mainly owing to the
blood–brain barrier that can successfully retard the drug
transvascular transport (Zhou et al., 2013). Convection-
enhanced delivery (CED) has been developed as an alterna-
tive to directly infuse the drug solution into the lesion. The
enhanced bulk flow of interstitial fluid is expected to
improve the drug penetration into deep tissue for better
therapy. The feasibility and safety of CED has been exten-
sively reported in the literature (Brady et al., 2011); however,
its applications in clinical trials for treating Parkinson’s dis-
ease (Marks et al., 2010) and brain cancers (Groothuis, 2000)
remain to be optimized and results so far have been some-
what disappointing. Follow-up analyses demonstrated that
the insufficient drug accumulation and difficulties to control
the drug spatial distribution are the main barriers to be over-
come for a better uptake of CED in clinical treatments
(Raghavan et al., 2006; Marks et al., 2010; Grondin
et al., 2019).
Intracerebral drug delivery involves multiple biophysical
and physicochemical processes determined by drug transport
properties, biological properties of the brain and their inter-
plays. Brain tissue is highly anisotropic due to the wide
distribution of nerve fibers, resulting in the significant varia-
tions of tissue permeability and drug diffusivity in different
directions which were found to strongly influence drug trans-
port (Zuzana & Sykova, 1998). Given the anisotropy could
change in a large range depending on the location, organ-
ization and distribution of nerve fibers, examining the per-
formances of various drugs under different anisotropic
conditions could deepen understanding on the effects of
anisotropic properties on CED treatments and optimize the
treatment planning.
Numerical simulation has become a promising approach
to study drug delivery because of its advantage in examining
the complex drug transport processes integrally or in an indi-
vidual manner (Sefidgar et al., 2014; Steuperaert et al., 2017;
Zhan et al., 2019; Manshadi et al., 2019). The modeling
framework in the general form was firstly setup to study the
intravenous administration of antibodies in different in vivo
environments (Baxter & Jain, 1989, 1990, 1991) and was fur-
ther tailored to predict drug transport in CED treatments
(Støverud et al., 2012; Zhang et al., 2012). Brain was simpli-
fied as an isotropic domain in most of the previous studies
owing to the lack of supports from the experimental meas-
urements (Arifin et al., 2009; Zhang et al., 2009). As an
improvement, a calibration algorithm was developed to
derive the brain anisotropy from dMRI data (Linninger et al.,
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2008) and has been applied in the study to understand the
influence of particular infusion locations on the intracerebral
transport of trophic factor.
In the present study, a multiphysics model is applied to a
2D axis-symmetric geometry with the aim to examine the
impacts of anisotropic characterization on the delivery of dif-
ferent drugs upon CED. The model covers the key drug deliv-
ery processes; these include convective transport with
interstitial fluid flow, diffusion in the tissue interstitial space,
binding with proteins, cell uptake, and elimination due to
blood drainage, metabolism and physical degradation. The
delivery outcomes are evaluated in terms of the penetration
depth and delivery volume in which the concentration of
each drug is greater than its LD90.
2. Material and methods
2.1. Mathematical model
Given that the inter-capillary distance is orders lower than
the drug transport dimension, brain tissue is commonly
treated as a porous medium (Baxter & Jain, 1989), which is
fully saturated with the incompressible, Newtonian interstitial
fluid. The infinitesimal tissue deformation during CED infu-
sion is described by the linear solid mechanics model (Su
et al., 2011) in the form of
Gr2uþ kþ Gð Þr r  uð Þ ¼ r tISpið Þ (1)
where u stands for the tissue displacement vector, and k
and G are tissue Lame constants. tIS refers to the fraction of
tissue interstitial space which is determined by the tissue
deformation as tIS ¼ tIS;0 þ eð Þ= 1þ eð Þ; where e ¼ r  u; and
tIS;0 refers to the initial value. pi is the interstitial fluid pres-
sure that is governed by the mass and momentum conserva-
tion equations (Baxter & Jain, 1989), as follows:
r  v ¼ Lb SV pbpirT pbpið Þ½ 
q v  rvð Þ ¼ tISrpi þ lr2vtIS lj v
(2)
where q and l are the interstitial fluid density and viscosity,
respectively, and v refers to the interstitial fluid velocity. Lb is
the hydraulic conductivity of blood vessel wall, and S/V is
the area of blood vessel per tissue volume. pb is the blood
pressure. pb and pi denote the osmotic pressure of blood
and interstitial fluid, respectively. j is the tissue permeability
which is governed by j ¼ j0exp Með Þ upon tissue deform-
ation, where M is a non-dimensional parameter describing
the properties of tissue extracellular matrix and j0 is the ini-
tial tissue permeability before CED infusion takes place (Su
et al., 2011).
The brain tissue can briefly be divided into three compart-
ments, including interstitial space (IS), cell membrane (CM)
and cell interior (CI). The concentration (C) of free drugs (F)
and drugs that bind with proteins (B) are governed by the
mass conservation equations as
CF ¼ tISCF;IS þ tCICF;CI þ tCMCF;CM
CB ¼ tISCB;IS þ tCICB;CI þ tCMCB;CM (3)
where t refers to the volume fraction. It is assumed that
there is no drug either being eliminated or associated with
proteins on CM (Arifin et al., 2009). Free drug accumulation
in the whole brain is determined by convective and diffusive
transport in IS, binding with proteins, cell uptake and elimin-
ation due to the loss to blood circulatory system, physical
degradation and metabolism. Therefore, the concentration of
free drugs in the entire tissue is described by
oCF
ot
¼tISDISr2CF;IS r  tISvCF;ISð Þ
 tIS kb þ keð ÞCF;IS  tCIkeCF;CI  oCBot
(4)
where D is the drug diffusivity. kb and ke refer to the elimin-
ation rate due to the blood drainage and degradation/
metabolism, respectively. Two assumptions are further intro-
duced for simplification: The linear correlation is established
between the free and bound drug concentration (Eikenberry,
2009) (KCI ¼ CB;CI=CF;CI; KIS ¼ CB;IS=CF;IS) and the equilibrium
of free drug concentration is achieved among IS, CM and
CI (Saltzman & Radomsky, 1991) (PCIIS ¼ CF;CI=CF;IS;
PCMIS ¼ CF;CM=CF;IS). As such, Equation (4) can be rewritten
as (Arifin et al., 2009)
oCF;IS
ot
¼ DISr2CF;IS  v  rCF;IS  kelimCF;IS (5)
in which DIS ¼ tIS=xð ÞDIS is the drug apparent diffusivity,
and v ¼ tIS=xð Þv is the apparent interstitial fluid velocity.
kelim ¼ tISkb þ tIS þ tCIð Þke þ Fv½ =x is the drug apparent
elimination rate. Fv ¼ Kb SV pbpirT pbpið Þ½  stands for
the fluid flux from blood and x ¼ tIS 1þ KISð Þ þ
tCIPCIIS 1þ KCIð Þ þ 1tIStCIð Þ PCMIS:
2.2. Model geometry
The mathematical modeling of CED is performed in a 2D
axis-systematic configuration (Su et al., 2011) as depicted in
Figure 1. The radius of tissue domain is 20mm (Su et al.,
2010), and drugs are infused through a catheter with the
inner and outer diameter of 0.15 and 0.238mm, respectively.
The final computational mesh generated in COMSOL (Su
et al., 2011) consists of 50,000 triangular elements after con-
ducting the mesh independent test. The smallest elements in
5E-3mm are imposed on the needle wall and infusion site
for the high resolution of numerical solutions.
Figure 1. Model geometry for simulation.
774 W. ZHAN ET AL.
2.3. Model parameters
Given that the simulation time window of CED treatments is
much shorter as compared to the tissue growth, drug trans-
port properties and geometric parameters are assumed to be
independent of time. However, the variation of many param-
eters must still be captured in the simulations; these include
physical and transport properties for the tissue and different
drugs. Essential model parameters and their related sources
are summarized in Table S1 and Table S2. The infusion con-
centration (Cin) of each drug is set as its solubility, and the
effective therapeutic concentration (Ceff) refers to the drug
dose which is sufficient to kill 90% of cultured cells as meas-
ured in ex vivo experiments. Justifications for the choices of
the key parameters are given below.
Infusion rate (Rin): The infusate is administrated at a con-
stant flow rate in CED treatments. However, the infusion rate
needs to be controlled well in order to avoid potential dam-
ages to the brain tissue (Allard et al., 2009). Given this rate is
recommended to be less than 5.0 lL/min (Raghavan et al.,
2006; Mardor et al., 2001), it is set as 1.0lL/min in this study.
Tissue permeability (j): Tissue permeability characterizes
the capacity of brain tissue to enable substances’ transport
through the tissue extracellular matrix. It depends on the
local tissue microstructure, arrangement of nerve fibers, etc.
Values in the range from E-15 to E-14 m2 were recorded and
applied for the permeability of human brain tissue in differ-
ent contributions (Kaczmarek et al., 1997; Linninger et al.,
2008; Wagner and Ehlers, 2010; Smith et al., 2012; Vidotto
et al., 2019). Hence, a mid-range value of tissue permeability,
assumed to be 6.4E-15 m2 (Arifin et al., 2009), is used in
this study.
Drug diffusivity (D): Diffusivity represents the drug trans-
port capacity driven by its concentration gradient in brain
tissue. It is determined by several factors including the drug
molecular weight, viscosity of interstitial fluid, temperature,
tissue microstructure, nerve fiber arrangement, etc. Here, the
diffusivity of doxorubicin is estimated based on its molecular
weight and the empirical formula that was derived from the
experimental measurements in Swabb et al. (1974). Values
for the rest of the drugs are extracted from experiment
measurements, whose details are reported in the references
provided in Table S2.
Calibration of anisotropy: The anisotropy of brain tissue
is usually measured by the apparent water diffusion tensor
(WDT) using dMRI. As shown in Figure 2(A), given that the
WDT at each pixel can be decomposed into the principal
directions (ei) and corresponding principal values (ni), the
anisotropy of local transport properties (D and j) are calcu-
lated by scaling the isotropic values with the normalized
WDT principal values in each direction (Sarntinoranont et al.,
2003). Following this procedure, the anisotropy of D and j in
the present study is calibrated by
jaxial ¼ jkaxial





in which k denotes how anisotropic the tissue is in the each
principle direction, as shown in Figure 2(B). The angle h ¼
acot kaxial=kradialð Þ is introduced to measure the degree of
local anisotropy, with h ¼ 45o corresponding to iso-
tropic tissue.
In reality, the anisotropy of brain tissue could be consider-
ably different depending on the local arrangements of nerve
fibers (Melhem et al., 2002). Image analyses have shown that
the tissue is relatively isotropic in the region close to puta-
men (Linninger et al., 2008); however, the maximum principle
value could be 10 times higher than the minimum one near
the corpus callosum (Linninger et al., 2008). Measurements
based on dMRI (Linninger et al., 2008; Kim et al., 2012; Ehlers
& Wagner, 2015; Dai et al., 2016) suggest that the anisotropic
angle h could vary in a wide range of (2, 80) throughout
the entire brain.
To cover this measured range, the anisotropic angle h is
swept from 0 to 90 and a continuous parametric scan is
performed to study the impact of diffusivity anisotropy.
Given the limitation of nonzero component of j as defined
in Equation (2), the range of 189 is applied for tissue per-
meability. It is important to point out that the parameter k is





is done to feature the same baseline for cross-comparisons.
However, relaxing this constrain could rescale the baseline of
D and j, and thereby divert the study focus to the magni-
tude of D and j rather than their anisotropy. As the impacts
of the magnitude of D and j have been studied elsewhere,
see e.g. Liu et al. (2010), they will not be included in
this study.
2.4. Boundary conditions
The tissue external surface is assumed to be fixed with no
displacement upon CED infusion, and the gauge pressure
and drug flux are assumed to be zero (Garc~Aa et al., 2013).
Constant velocity and drug concentration are specified on
the catheter tip, where the tissue displacement is determined
by the local pressure. The tissue contacting to the catheter
wall could deform depending on the local stress, and the
catheter is assumed to be rigid with no slip or drug flux
through its surface (Su et al., 2011).
2.5. Quantification index
Drug delivery outcomes in CED treatments under different
conditions are evaluated in terms of drug accumulation and
pharmacological effect represented by the quantitative
indexes defined below.
2.5.1. Effective penetration depth (DPeff)
Drug transport from the infusion site is not uniform in the
brain. DPeff is used to examine the drug effective accumula-
tion in different directions, defined as
DPeff ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
xix0ð Þ2 þ yiy0ð Þ2
q
(7)
where (x0; y0) is the coordinates of the center of infusion
site, and (xi; yi) is the point where the drug concentration
reduces to the effective therapeutic concentration (Ceff).
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2.5.2. Effective delivery volume (Veff)
Treatment efficacy is evaluated in terms of the effective
delivery volume, in which the drug interstitial concentration
(CF,IS) in above the threshold of Ceff.
Veff ¼
X
Vi CF;IS  Ceffð Þ (8)
in which Vi is the local element volume.
2.5.3. Enhancement
A dimensionless number is introduced to access the effect of
anisotropic properties on delivery outcomes in terms of
either DPeff or Veff, defined as
Enhancement ¼ Delivery outcomes with anisotropic propertiesDelivery outcomes with isotropic properties (9)
3. Results
3.1. Drug delivery in isotropic tissue
Drug transport and accumulation in CED treatments are
strongly dependent on the mechanical environment of brain,
which is predicted by solving the governing equations in the
whole domain and subjected to the aforementioned bound-
ary conditions and parameters in Table S1. Results in Figure
3(A) demonstrate that CED infusion can build up the intersti-
tial fluid pressure around the infusion site. This raised pres-
sure, on the one hand, is able to increase the interstitial fluid
velocity and thereby enhance the drug convective transport
for better drug penetration. On the other hand, the pressure
difference across blood vessel wall is reduced, resulting in
the reduction of fluid loss from the blood to prevent the
Figure 2. Calibration of anisotropy. (A) Derivation of anisotropy of transport properties from the local WDT. (B) Calibration procedure for parametric study.
Figure 3. Delivery in isotropic tissue. (A) Biomechanics in brain with isotropic properties. (B) Delivery outcomes of different drugs. Penetration depth in (a) axial
and (b) radial direction, and (c) distribution volume.
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drug concentration being diluted. The CED infusion leads to
high strain around the infusion site and along the catheter
track, while the impact in other regions is insignificant.
The predicted effective penetration depths (DPeff) in the
axial and radial direction are compared for different drugs in
Figure 3(B). Results show that paclitaxel presents the best
penetration. It is followed by methotrexate, carmustine, fluo-
rouracil and cisplatin, whereas the most limited penetration
is found for doxorubicin. As a consequence, the effective
delivery volumes of different drugs follow the same order.
3.2. Effect of anisotropic tissue permeability
The effects of anisotropic tissue permeability on the trans-
port of each drug are examined by changing the axial and
radial components with the anisotropic angle h in the range
from 1 to 89, with respect to the baseline values of iso-
tropic tissue as shown in Table S1. Other biological proper-
ties of brain tissue and transport properties of drugs are
constant and isotropic.
The mechanical environments in the tissue with different
anisotropic permeability conditions are represented in Figure
4. Comparisons show that the highest interstitial fluid pres-
sure and tissue strain are achieved when the tissue perme-
ability in the axial direction is dominant (h¼ 1). As a result,
the interstitial fluid mainly flows along the catheter track.
The interstitial fluid flow can be directed to the radial direc-
tion (as defined in Figure 2) with the increase of anisotropic
angle, suggesting the flow velocity is positively related to
the tissue permeability in the corresponding directions.
The spatial distributions of each drug in the tissues with
different anisotropic tissue permeability are compared in
Figure 5(A). Results demonstrate that increasing the aniso-
tropic angle can effectively enhance the drug radial penetra-
tion, while the drug penetration in the axial direction is
simultaneously reduced. The enhancements on drug penetra-
tion and delivery volume induced by the anisotropic tissue
permeability are calculated based on Equation (9), and fur-
ther compared in Figure 5(B) as a function of the anisotropic
angle h. Results denote that cisplatin and doxorubicin are the
most sensitive drugs to the tissue permeability anisotropy.
They are followed by methotrexate, fluorouracil, paclitaxel and
carmustine in orders. The drug axial penetration has a more
significant response to the anisotropy of tissue permeability.
However, the anisotropic tissue permeability has limited
impacts on the effective delivery volumes of all the exam-
ined drugs.
3.3. Effect of anisotropic diffusivity
The impact of anisotropic diffusivity is examined by changing
the anisotropic angle in the range from 0 to 90 in this
parametric study, while the rest properties are kept constant
and isotropic. Modeling results of the spatial distributions of
drug effective accumulation are shown in Figure 6(A). It is
not surprising that the relatively uniform distribution of all
drugs is achieved when the diffusivity is isotropic. Increasing
the anisotropic angle can effectively increase the radial pene-
tration, while the penetration depth in the axial direction is
reduced, indicating the positive relationship between the
penetration depth and the corresponding diffusivity compo-
nent in the same direction.
Figure 6(B) represents the anisotropic diffusion-induced
enhancements on DPeff and Veff as a function of h. Results
denote that the effective penetration of each drug present
different sensitivities to the diffusivity anisotropy. As com-
pared to cisplatin and doxorubicin, paclitaxel and methotrex-
ate are able to transport farther into the deep region of
anisotropic brain tissue. Moreover, the anisotropic diffusivity
is more influential on the drug penetration in the axial
Figure 4. Biomechanics in brain with anisotropic tissue permeability.
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direction. The enhancements on effective delivery volume
are highly dependent on the drug. Modeling predictions
show that the largest effective delivery volumes of fluoroura-
cil, carmustine, cisplatin and doxorubicin can be achieved in
the tissue where diffusivity is relatively isotropic, while
changes in the diffusivity anisotropy could result in signifi-
cant reduction in tissue volume for effective therapy. On the
contrary, the delivery volume of paclitaxel and methotrexate
can be largely improved by diffusivity anisotropy, with the
largest coverage achieved when the drugs are diffused best
in the axial direction.
4. Discussion
CED is designed to improve the drug delivery by means of
generating a friendly mechanical environment for drug trans-
port. On the one hand, the enhanced bulk movement of
interstitial fluid flow by CED infusion can improve the con-
vective transport of drugs in the tissue interstitial space. On
the other hand, the infusion-induced high interstitial fluid
pressure is capable of reducing the flow loss from blood to
prevent the drug concentrations being diluted. Delivery out-
comes are determined by the interplay between the drugs
Figure 5. Effect of anisotropic tissue permeability on delivery outcomes of different drugs. (A) Spatial distribution of effective drug concentration. (B) Enhancement
on drug effective penetration and delivery volume as a function of anisotropic angle of h in the range of 1o to 89o.
Figure 6. Effect of anisotropic diffusivity on delivery outcomes of different drugs. (A) Spatial distribution of effective drug concentration. (B) Enhancement on drug
effective penetration and delivery volume as a function of anisotropic angle of h in the range of 0o to 90o.
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and the biological system. Modeling results denote that the
effective penetration depth of all the examined drugs can be
improved in a given direction by increasing the component
of diffusivity and tissue permeability anisotropy in the same
direction, which in turn requires catheters in some locations
to be placed with respect to the brain matter as both diffu-
sivity and permeability are affected by e.g. the distribution of
axons within white matter.
Directionality of tissue response and local variations of dif-
fusivity and permeability can now be considered when plan-
ning a neurosurgical operation. As a promising alternative to
the rigid catheters that are directly inserted into the brain, a
multisegment catheter has been developed (Oldfield et al.,
2013) to improve the drug distribution with respect to the
local anisotropic properties. The steering direction can be
controlled during insertion by adjusting the relative move-
ment of each segment. As such, this flexible catheter (Watts
et al., 2019) can follow the predesigned curved trajectory
(Pinzi et al., 2019) to reach the targeted location with speci-
fied orientation for drug releasing (Oldfield et al., 2014), in
order to enlarge the delivery volume for improved therapy.
Here, we show how the response to anisotropic character-
istics differs for different drugs. The penetration of paclitaxel
presents high sensitivity to the diffusivity, while the changes
of tissue permeability have more significant impacts on cis-
platin and doxorubicin. Modeling predictions demonstrate
that the tissue permeability could influence the drug pene-
tration depth but has little contribution to the effective deliv-
ery volume. This is different from diffusivity that the
treatment efficacy is strongly dependent on. Owing to the
different sensitivities as shown in Figure 6, fluorouracil, car-
mustine, cisplatin and doxorubicin are preferable to be
infused into the region where the diffusivity is less aniso-
tropic, while paclitaxel and methotrexate are suitable to be
delivered into tissue regions with significantly anisotropic dif-
fusivity to improve the treatment efficacy.
The anisotropy of tissue permeability and drug diffusivity
are usually assumed to vary in the same pattern (Linninger
et al., 2008). In order to understand how the delivery out-
comes of six different drugs behave in response to these
anisotropic characteristics, the effects of tissue permeability
and diffusivity are examined individually in this parameter
study. Tissue stiffness could also be highly anisotropic in
brain owing to the presence of nerve fibers. However, rather
than directly determining the drug transport, anisotropic
stiffness mainly influences the drug delivery by means of
changing the local tissue permeability (Su et al., 2011; Kim
et al., 2012). Therefore, the effect of tissue stiffness on the
local tissue deformation has not been studied separately.
Simulations in this study are based on a two-dimensional
axis-systematic geometry, as shown in Figure 1. Although
this idealized geometry with the same dimension has been
applied to study drug delivery before (Su et al., 2010), there
still is a concern that the difference between the 2D ideal-
ized and 3D realistic models could significantly affect the
results. To this end, additional simulations under the same
delivery conditions are carried out based on a 3D brain
model reconstructed from MR images, as shown in Figure S1.
Results are summarized in Figure S2 and show that the mod-
eling predictions are comparable, with very small differences
obtained for all drugs adopted in this study. Therefore, the
use of 2D idealized geometry is certainly acceptable for
qualitatively comparing the drug delivery outcomes in the
parametric study with affordable computational cost (Baxter
& Jain, 1989; Su et al., 2011), while 3D models reconstructed
from medical images (Zhan & Wang, 2018) may be required
to obtained accurate predictions in patient-specific and more
realistic clinical configurations, especially when the infusion
is affected by the presence of strong gradients in local prop-
erties and tissue boundaries near the infusion site.
The feasibility of mathematical model in simulating drug
delivery has been reported in several studies. The interstitial
fluid velocity was calculated as 0.17lm/s (Baxter & Jain,
1989), which was well within the experimental range of
0.13 0.2 lm/s (Butler et al., 1975). The model-predicted
interstitial fluid pressure was 40 and 1500 Pa in tumor and
normal tissue, respectively (Zhan et al., 2014); the experimen-
tal measurements for these two types of tissues were
400 800 Pa and 587 4200 Pa (Raghunathan et al., 2010).
The drug transport model was validated in gel-based experi-
ments on CED of albumin and Evan blue. In terms of the
delivery volume, the coefficients of multiple determination of
0.8 and 0.7 were achieved for each marker, respectively
(Neeves et al., 2006). A similar comparison can be found in
Figure S3, where the predicted concentration of bromophe-
nol blue dye in gel agrees to the experiment. The estab-
lished model is further validated by comparing with ourin
vivo experiments in Figure S4–S6. In the experiments, the
gadolinium solution is continuously infused into the ovine
brains at three different locations, and MR imaging is used
to measure the spatial distributions. Comparisons demon-
strate that the established model is capable of providing
qualitative predictions of delivery outcomes. Similar valida-
tions were reported in literatures (Arifin et al., 2009; Arifin
et al., 2009; Ranganath et al., 2010), where the simulated pro-
files of carmustine, paclitaxel, fluorouracil and methotrexate
were found to be qualitatively comparable to the results
obtained in animal experiments. By employing the transport
properties calculated based on the in vivo data, the model-
predicted accumulation profiles of nanoparticles could be
quantitatively comparable to the animal experimental results
(Zhan et al., 2017). In summary, modeling predictions enable
comparing delivery results in a qualitative manner. The pre-
dictions can be applied to examine the impact of different
factors and thereby provide opportunities to optimize the
CED treatment regimes.
Although this study offers new insight into how aniso-
tropic characteristics influence the CED treatment, the model
involves several assumptions. (i) Anisotropy in the whole
brain can vary significantly across the tissue; however, the
local anisotropy varies gradually with respect to the continu-
ous nerve fibers, as indicated by brain tractography (Catani
et al., 2003; Lawes et al., 2008). Henceforth, the same anisot-
ropy characteristics are assumed in the whole simulation
domain that represents a small tissue region near the infu-
sion site. This assumption can be relaxed with the additional
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supports of diffusion tensor imaging, from which pixel-wise
anisotropic information can be acquired (Sarntinoranont
et al., 2006). (ii) As shown in Figure 2(B), the infusion catheter
is usually aligned with the principle directions of anisotropy.
Breaking this alignment would introduce another variable in
the definition of the infusion angle, which stands for the
infusion orientation and catheter pose, as indicated by
Figure S7. This is outside the scope of the present contribu-
tion and will be examined in future studies. (iii) The infusate
concentration is set as the drug maximum solubility in water,
as summarized in Table S2. Given the infusate is drug-diluted
solution, the viscosity of infusate is assumed to be constant
in all the simulations. However, it is worth to point out that
the viscosity could be significantly changed if the infusate is
suspension or emulsion. As a result, the effect of viscosity on
drug accumulation and penetration should be considered.
(iv) The biological properties of tissue and transport proper-
ties of drugs can also change with temperature. It is reason-
able to assume the body temperature remaining at a
constant level for human. However, the temperature-induced
variation needs to be included for those who have inflamma-
tion or are under thermal treatments, such as ultrasound
hyperthermia, etc. (v) Stationary simulations are performed in
this study. This is because, on the one hand, the continuous
CED infusion could last for several days in clinical treatments
(Mardor et al., 2001); on the other hand, as a result of the
equilibrium achieved between the source term of infusion
and the sink term of elimination, the drug accumulation and
penetration could reach a quasi-steady state after a few
hours (Zhan & Wang, 2018). It is worth pointing out that the
model is developed in its more general transient form, which
enables predicting the spatiotemporal profiles of drug trans-
port in CED. (vi) The drug binding with proteins and the
drug partitioning in different tissue compartments are
assumed to have reached equilibrium. This is because the
time scale for these two-way interactions (association/disas-
sociation and influx/efflux) is in minutes (Liu et al., 2011),
while the drug penetration and accumulation could remain
at the quasi-steady state for days (Mardor et al., 2001). The
dynamic processes of drug binding and cell uptake can be
examined by employing models reported in e.g. McGinty and
Pontrelli (2015) and Liu et al. (2013), which the reader is
invited to refer to for further details.
5. Conclusions
The effects of tissue permeability and drug diffusion anisot-
ropy on the CED of six drugs have been studied based on a
multiphysics model. Results demonstrate that CED infusion
can successfully increase the interstitial fluid pressure and
velocity around the infusion site. This hydraulic environment
could be beneficial to improve the convective drug transport
and reduce the fluid loss from blood circulatory system to
prevent the concentration dilution. Drug penetration depth
in each direction is positively related to the corresponding
component of diffusivity and tissue permeability in the same
direction. The anisotropic tissue permeability could effect-
ively influence the drug spatial distribution but has limited
impact on the effective delivery volume. On the contrary, the
parameter study on anisotropic diffusivity shows that treat-
ment efficacy of fluorouracil, carmustine, cisplatin and doxo-
rubicin can be improved by infusing drugs into the relatively
isotropic tissue, while the effective delivery volume of pacli-
taxel and methotrexate can be significantly enlarged in aniso-
tropic tissue. Results obtained from this study can be applied
as a guide for optimizing CED treatments.
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